0001209191-14-073398.txt : 20141205
0001209191-14-073398.hdr.sgml : 20141205
20141205162557
ACCESSION NUMBER: 0001209191-14-073398
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20141204
FILED AS OF DATE: 20141205
DATE AS OF CHANGE: 20141205
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Connolly Thomas
CENTRAL INDEX KEY: 0001453943
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 141269913
MAIL ADDRESS:
STREET 1: 717 FIFTH AVENUE
STREET 2: 9TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10022
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2014-12-04
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001453943
Connolly Thomas
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
0
1
0
0
SVP, Human Resources
Common Stock
2014-12-04
4
M
0
937
53.74
A
35832
D
Common Stock
2014-12-04
4
S
0
500
118.40
D
35332
D
Common Stock
2014-12-04
4
S
0
337
119.36
D
34995
D
Common Stock
2014-12-04
4
S
0
100
120.62
D
34895
D
Common Stock
150
I
401(k)
Stock Option (right to buy)
53.74
2014-12-04
4
M
0
937
0.00
D
2022-09-03
Common Stock
937
6563
D
Transaction made pursuant to Mr. Connolly's company approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $118.40 (range $117.92 to $118.86).
Mr. Connolly undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $119.36 (range $118.95 to $119.82).
The option vests in 16 quarterly installments from 09/04/2012.
Omar White, Attorney-In-Fact
2014-12-05